Remote ischaemic preconditioning to protect the myocardium during abdominal aortic aneurysm repair

ISRCTN ISRCTN48315424
DOI https://doi.org/10.1186/ISRCTN48315424
Secondary identifying numbers N0544122070
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
16/07/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Ziad Ali
Scientific

Department of Vascular Surgery
Box 201
Addenbrooke's Hospital
Long Road
Cambridge
CB2 2QQ
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesPatients undergoing major vascular surgery are at significant risk of developing postoperative myocardial complications, particularly myocardial infarction. Protecting the heart during the perioperative period could provide a method to reduce morbidity and mortality after vascular surgery. Ischaemic preconditioning is a well recognised phenomenon, whereby a brief period of ischaemia followed by reperfusion prior to a prolonged ischaemic event can provide protection from cellular injury. Protection can be performed either by a stimulus to the myocardium itself or by ischaemia at a site distant to the heart. The aim of this study is to determine whether remote ischaemic preconditioning confers a reduction in myocardial damage in patients undergoing abdominal aortic aneurysm repair.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedAortic aneurysm repair
InterventionRandomised controlled trial:
1. Abdominal aortic aneurysm repair alone
2. Abdominal aortic aneurysm repair with intermittent cross clamping/perfusion of common iliac artery
Postoperatively, patients will have cardiac troponin and creatine kinase MB (CKMB) recorded on days 1, 3 and 7. Holter monitoring is to be continued until 48 h post operation.
Intervention typeOther
Primary outcome measureA reduction in myocardial damage as assessed by serum measurement of cardiac troponin and Holter electrocardiogram.
Secondary outcome measuresNot provided at time of registration
Overall study start date10/01/2003
Completion date09/01/2006

Eligibility

Participant type(s)Patient
Age groupOther
Lower age limit18 Years
Upper age limit90 Years
SexBoth
Target number of participants72
Key inclusion criteria72 Subjects aged 18-90.
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment10/01/2003
Date of final enrolment09/01/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Vascular Surgery
Cambridge
CB2 2QQ
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Research council

Cambridge Consortium - Addenbrookes (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 11/09/2007 Yes No